# Walking Estimated Limitation Calculated by History - Study 2

Study · id `cardio:ct-nct01424020` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01424020](<https://clinicaltrials.gov/study/NCT01424020>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01424020

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

## Technical summary

Registry record NCT01424020. Non-randomized; no masking; primary purpose diagnostic. Start 2011-09 (registry gives no type); primary completion 2017-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT01424020, source copy `cardio:ctgov-nct01424020-2016-12-19`, retrieved 2026-10-31)
- Start date: 2011-09 (registry gives no type) (ClinicalTrials.gov record NCT01424020, source copy `cardio:ctgov-nct01424020-2016-12-19`, retrieved 2026-10-31)
- Primary completion: 2017-11 (anticipated) (ClinicalTrials.gov record NCT01424020, source copy `cardio:ctgov-nct01424020-2016-12-19`, retrieved 2026-10-31)
- Completion: 2017-11 (anticipated) (ClinicalTrials.gov record NCT01424020, source copy `cardio:ctgov-nct01424020-2016-12-19`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT01424020, source copy `cardio:ctgov-nct01424020-2016-12-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01424020-2016-12-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: Walking Estimated Limitation Calculated by History - Study 2
- Acronym: WELCH-2
- Condition: Peripheral Artery Disease
- Intervention (Other): Questionnaire
- Lead sponsor: University Hospital, Angers
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Angers (`cardio:org-university-hospital-angers`)

## Provenance

Content hash: 389d40edc703d3ff1e52628ebc2205efa78694b205b66b5eb9202bc2750f34eb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
